Harvard Apparatus Regenerative Technology Inc (OTCPK:HRGN)
$ 2.68 0.36 (15.52%) Market Cap: 38.36 Mil Enterprise Value: 32.83 Mil PE Ratio: 0 PB Ratio: 22.33 GF Score: 34/100

Q3 2022 Biostage Inc Earnings Call Transcript

Nov 15, 2022 / 02:00PM GMT
Release Date Price: $6.3 (-8.70%)
Operator

Greetings and welcome to the Biostage Q3 2022 conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host today, Joe Damasio, Chief Financial Officer. Please proceed, sir.

Joe Damasio
Biostage, Inc. - CFO

Good morning. This is Joe Damasio. On the call with me today is David Green, our Interim Chief Executive Officer.

Before I turn it over to David, let me review the company's forward-looking statements. In our discussion today, we may make statements that constitute forward-looking statements. Our actual results and performance may differ materially from what we have previously projected due to risks and uncertainties, including those the details in our annual report on Form 10-K for the year ended December 31, 2021, and our other public filings.

Any forward-looking statements, including those related to our future results and activities, represent our estimates as of today and should not be relied upon as representing our estimates at any subsequent day.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot